Company Aoxing Pharmaceutical Company Inc Nyse
Equities
US03740A1060
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Narcotics & Pain Management Products
100.0
%
| 25 | 100.0 % | 32 | 100.0 % | +26.88% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Cnina
100.0
%
| 25 | 100.0 % | 32 | 100.0 % | +26.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 23-08-10 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 10-12-31 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 23-08-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,209,195 | 76,209,195 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B |